Cargando…

Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells

BACKGROUND: CD4(+)CD25(+) regulatory T cell (Treg)-based immunotherapy is considered a promising regimen for controlling the progression of autoimmune diabetes. In this study, we tested the hypothesis that the therapeutic effects of Tregs in response to the antigenic epitope stimulation depend on th...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Guojiang, Han, Gencheng, Feng, Jiannan, Wang, Jianan, Wang, Renxi, Xu, Ruonan, Shen, Beifen, Qian, Jiahua, Li, Yan
Formato: Texto
Lenguaje:English
Publicado: Public Library of Science 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736381/
https://www.ncbi.nlm.nih.gov/pubmed/19759824
http://dx.doi.org/10.1371/journal.pone.0007034
_version_ 1782171328447512576
author Chen, Guojiang
Han, Gencheng
Feng, Jiannan
Wang, Jianan
Wang, Renxi
Xu, Ruonan
Shen, Beifen
Qian, Jiahua
Li, Yan
author_facet Chen, Guojiang
Han, Gencheng
Feng, Jiannan
Wang, Jianan
Wang, Renxi
Xu, Ruonan
Shen, Beifen
Qian, Jiahua
Li, Yan
author_sort Chen, Guojiang
collection PubMed
description BACKGROUND: CD4(+)CD25(+) regulatory T cell (Treg)-based immunotherapy is considered a promising regimen for controlling the progression of autoimmune diabetes. In this study, we tested the hypothesis that the therapeutic effects of Tregs in response to the antigenic epitope stimulation depend on the structural properties of the epitopes used. METHODOLOGY/PRINCIPAL FINDINGS: Splenic lymphocytes from nonobese diabetic (NOD) mice were stimulated with different glutamic acid decarboxylase (GAD)-derived epitopes for 7–10 days and the frequency and function of Tregs was analyzed. We found that, although all expanded Tregs showed suppressive functions in vitro, only p524 (GAD524–538)-expanded CD4(+)CD25(+) T cells inhibited diabetes development in the co-transfer models, while p509 (GAD509–528)- or p530 (GAD530–543)-expanded CD4(+)CD25(+) T cells had no such effects. Using computer-guided molecular modeling and docking methods, the differences in structural characteristics of these epitopes and the interaction mode (including binding energy and identified domains in the epitopes) between the above-mentioned epitopes and MHC class II I-A(g7) were analyzed. The theoretical results showed that the epitope p524, which induced protective Tregs, possessed negative surface-electrostatic potential and bound two chains of MHC class II I-A(g7), while the epitopes p509 and p530 which had no such ability exhibited positive surface-electrostatic potential and bound one chain of I-A(g7). Furthermore, p524 bound to I-A(g7) more stably than p509 and p530. Of importance, we hypothesized and subsequently confirmed experimentally that the epitope (GAD570–585, p570), which displayed similar characteristics to p524, was a protective epitope by showing that p570-expanded CD4(+)CD25(+) T cells suppressed the onset of diabetes in NOD mice. CONCLUSIONS/SIGNIFICANCE: These data suggest that molecular modeling-based structural analysis of epitopes may be an instrumental tool for prediction of protective epitopes to expand functional Tregs.
format Text
id pubmed-2736381
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-27363812009-09-17 Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells Chen, Guojiang Han, Gencheng Feng, Jiannan Wang, Jianan Wang, Renxi Xu, Ruonan Shen, Beifen Qian, Jiahua Li, Yan PLoS One Research Article BACKGROUND: CD4(+)CD25(+) regulatory T cell (Treg)-based immunotherapy is considered a promising regimen for controlling the progression of autoimmune diabetes. In this study, we tested the hypothesis that the therapeutic effects of Tregs in response to the antigenic epitope stimulation depend on the structural properties of the epitopes used. METHODOLOGY/PRINCIPAL FINDINGS: Splenic lymphocytes from nonobese diabetic (NOD) mice were stimulated with different glutamic acid decarboxylase (GAD)-derived epitopes for 7–10 days and the frequency and function of Tregs was analyzed. We found that, although all expanded Tregs showed suppressive functions in vitro, only p524 (GAD524–538)-expanded CD4(+)CD25(+) T cells inhibited diabetes development in the co-transfer models, while p509 (GAD509–528)- or p530 (GAD530–543)-expanded CD4(+)CD25(+) T cells had no such effects. Using computer-guided molecular modeling and docking methods, the differences in structural characteristics of these epitopes and the interaction mode (including binding energy and identified domains in the epitopes) between the above-mentioned epitopes and MHC class II I-A(g7) were analyzed. The theoretical results showed that the epitope p524, which induced protective Tregs, possessed negative surface-electrostatic potential and bound two chains of MHC class II I-A(g7), while the epitopes p509 and p530 which had no such ability exhibited positive surface-electrostatic potential and bound one chain of I-A(g7). Furthermore, p524 bound to I-A(g7) more stably than p509 and p530. Of importance, we hypothesized and subsequently confirmed experimentally that the epitope (GAD570–585, p570), which displayed similar characteristics to p524, was a protective epitope by showing that p570-expanded CD4(+)CD25(+) T cells suppressed the onset of diabetes in NOD mice. CONCLUSIONS/SIGNIFICANCE: These data suggest that molecular modeling-based structural analysis of epitopes may be an instrumental tool for prediction of protective epitopes to expand functional Tregs. Public Library of Science 2009-09-13 /pmc/articles/PMC2736381/ /pubmed/19759824 http://dx.doi.org/10.1371/journal.pone.0007034 Text en Chen et al. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Chen, Guojiang
Han, Gencheng
Feng, Jiannan
Wang, Jianan
Wang, Renxi
Xu, Ruonan
Shen, Beifen
Qian, Jiahua
Li, Yan
Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
title Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
title_full Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
title_fullStr Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
title_full_unstemmed Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
title_short Glutamic Acid Decarboxylase-Derived Epitopes with Specific Domains Expand CD4(+)CD25(+) Regulatory T Cells
title_sort glutamic acid decarboxylase-derived epitopes with specific domains expand cd4(+)cd25(+) regulatory t cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2736381/
https://www.ncbi.nlm.nih.gov/pubmed/19759824
http://dx.doi.org/10.1371/journal.pone.0007034
work_keys_str_mv AT chenguojiang glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT hangencheng glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT fengjiannan glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT wangjianan glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT wangrenxi glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT xuruonan glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT shenbeifen glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT qianjiahua glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells
AT liyan glutamicaciddecarboxylasederivedepitopeswithspecificdomainsexpandcd4cd25regulatorytcells